November 6, 2019
Boston-based PathAI, maker of artificial intelligence tools for pathology, has capped off its Series B funding round with a $15 million strategic investment from the Merck Global Health Innovation Fund and Bristol-Myers Squibb. This raise brings the startup’s full round to $75 million, and its total funding to just over $90 million.
WHAT THEY DO
PathAI’s platform employs convolutional neural...
October 18, 2019
Health tech firm Healx, which specialises in treatments for rare diseases, has raised $56m (£43.4m) in a Series B financing round led by European VC firm Atomico and joined by Intel Capital, Global Brain and btov Partners.
All previous investors, including Balderton Capital, Amadeus Capital Partners, and Jonathan Milner also participated in the round. The funding follows a $10m Series A round in...
Credit: Ieso Digital Health
October 16, 2019
The digital therapeutics field has attracted the interest of major players in the healthcare industry lately, from big pharma to the NHS. But there is debate among stakeholders around issues including reimbursement, regulation and business models that work.
The space, however, continues to grow, and Cambridge-headquartered Ieso Digital Health unveiled earlier this year plans to build an...
October 15, 2019
Digital chronic disease management company Livongo Health announced a partnership today with VSP Vision Care that will blend each service for the companies’ mutual clients. More specifically, Livongo members with diabetes who are also under “most” VSP plans will be offered retinal screenings from VSP network doctors, and receive messages through the digital program prompting them to seek eye care...
October 15, 2019
French health tech startup Primaa has raised €2m to accelerate the development and the international marketing of its automated diagnostic products.
The Paris-based firm, founded in 2018, develops software tools which use artificial intelligence (AI) and deep learning to assist anatomical pathologists with cancer and other diagnoses.
It is currently in the process of finalising its first tool...
October 3, 2019
Diligent Robotics, maker of an autonomous robot assistant for hospitals, has raised $3 million in seed funding.
The raise was headed by True Ventures and Ubiquity Ventures, as well as Next Coast Ventures, Capital Factory, Pathbreaker Ventures, Boom Capital, Grit Ventures and other unnamed angel investors. This adds to another $2.1 million round announced back in the beginning of 2018, as well as...
October 1, 2019
Novartis is teaming up with Microsoft on a new artificial intelligence initiative focused on drug discovery and development. The new efforts will primarily be focused in Novartis’ newly announced AI innovation lab.
As part of the deal Novartis will be employing Microsoft’s AI tools to help its scientist with computational hurdles in life sciences including generative chemistry, image...
Kheiron founders Dr Peter Kecskemethy and Tobias Rijken (left to right)
September 25, 2019
Kheiron Medical Technologies, a startup that aims to help radiologists detect breast cancer earlier by using deep learning, has announced this week the closing of a $22m Series A round led by London-headquartered VC firm Atomico. Connect Ventures, Greycroft, Hoxton Ventures and EXOR Seeds, existing backers, also participated.
WHAT THEY DO
The startup was founded in 2016 by Peter Kecskemethy and...
September 18, 2019
This morning Google announced that the health team at DeepMind, an artificial intelligence Alphabet subsidiary primarily focused on research, is joining Google Health.
“Under the leadership of Dr. David Feinberg, and alongside other teams at Google, we’ll now be able to tap into global expertise in areas like app development, data security, cloud storage and user-centered design to build...
Credit: Huimei Healthcare
September 2, 2019
Originally founded in 2015 as a result of joint venture between Mayo Clinic and Hillhouse Capital, China’s Huimei Healthcare announced last week that it had closed $30M in Series C funding, led by Qiming Ventures and WuXi AppTech. The funds will be used by the company to develop its core-product, an AI-based Clinical Decision Support System (CDSS) called Dr Mayson, as well as for further product...